期刊文献+

血管内皮细胞生长因子在口腔鳞状细胞癌进展和预后中的作用研究进展 被引量:1

Research progress of vascular endothelial growth factor in progression and prognosis of oral squamous cell carcinoma
下载PDF
导出
摘要 血管内皮细胞生长因子(vascular endothelial growth factor,VEGF)是目前被鉴定出的最强的血管生长因子,其家族由7个配体、3种受体以及2种共受体组成。通过多条信号通路,VEGF表现出促进血管内皮细胞增殖和新生血管形成、淋巴内皮细胞生长和淋巴道转移、抗凋亡等多种细胞学效应。肿瘤的生长、转移及预后与VEGF密切相关,新生血管既为肿瘤生长提供营养,也为肿瘤的转移提供通道。本文针对VEGF及其受体的分子结构、信号机制、细胞学效应,以及其与口腔鳞状细胞癌(oral squamous cell carcinoma,OSCC)进展和预后的关系等进行综述。 Vascular endothelial growth factor (VEGF) has proven to be the most critical angiogenic factor identified to dates, whose family members are composed of 7 ligands, 3 receptors and 2 co-receptors. Through multiple signaling pathways, VEGF shows capacities of promoting vascular endothelial cell proliferation and angiogenesis, lymphatic endothelial cell growth and lymphatic metastasis, and antiapoptotic cell biology effect. Tumor growth, metastasis and prognosis are closely related with VEGF. Newly-born vessels provide nutrition for tumor growth, as well as providing channel for tumor migration. This review focused on the molecular structure of VEGF and its receptors, signal mechanisms, cytology effects, and its relation with progression and prognosis of oral squamous cell carcinoma (OSCC).
出处 《中国口腔颌面外科杂志》 CAS 2014年第2期175-178,共4页 China Journal of Oral and Maxillofacial Surgery
关键词 血管内皮细胞生长因子 口腔鳞状细胞癌 信号通路 Vascular endothelial growth factor Oral squamous cell carcinoma Signal pathway
  • 相关文献

参考文献26

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics,2002[J]. CA Cancer J Clin, 2005, 55(2): 74-108.
  • 2Yhee JY, Yu CH, Kim JH, et al. Angiogenesis and expression of vascular endothelial growth factor, tumour necrosis factor-α and hypoxia inducible factor-1α in canine renal cell carcinoma [J]. J Comp Pathol, 2012, 147(2-3): 129-138.
  • 3Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: review [J]. Blood Ceils Mol Dis, 2007, 38(3): 258-268.
  • 4Ambasta RK, Sharma A, Kumar P. Nanoparticle mediated targeting of VEGFR and cancer stem ceils for cancer therapy [J]. Vasc Cell, 2011, 3: 26.
  • 5Ahmann HK, Gertsch J. Anticancer drugs from nature-natural products as a unique source of new microtubule-stabilizing agents [J]. Nat Prod Rep, 2007, 24(2): 327-357.
  • 6Shen K, Ji L, Gong C, et al. Notoginsenoside Ftl promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways [J]. Biochem Pharmacol, 2012, 84(6): 784-792.
  • 7Feng Y, Hu J, Ma J, et al. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3- dependent axes-induced ERK, p38 and AKT signalling pathways[J]. Eur J Cancer, 2011, 47(15): 2353-2363.
  • 8Pan R, Dai Y, Gao XH, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways [J]. Vascul Pharmacol, 2011, 54 (1-2): 18-28.
  • 9Jesmin S, Zaedi S, Islam AM, et al. Time-dependent alterations of VEGF and its signaling molecules in acute lung injury in a rat model of sepsis [J]. Inflammation, 2012, 35(2): 484-500.
  • 10van den Akker NM, Caolo V, Molin DG, et al. Cellular decisions in cardiac out ow tract and coronary development: an act by VEGF and NOTCH [J]. Differentiation, 2012, 84(1): 62-78.

二级参考文献49

  • 1史文进,李慧增,杨军,孙远,容国俊,周树夏.颌面部爆炸伤软组织缺损早期修复的实验研究[J].实用口腔医学杂志,1996,12(4):264-266. 被引量:18
  • 2Stewart BW,Kleihues PE.International Agency for Re-search 2003[J].Acta Oncological,2003,43(5):506-507.
  • 3Hoffman HT,Karnell LH,Funk GF,et al.The nationalcancer data base report on cancer of the head and neck[J].Arch Otolaryngol Head Neck Surg,1998,124(9):951-962.
  • 4Khuri FR,Shin DM,Glisson BS,et al.Treatment of pa-tients with recurrent or metastatic squamous cell carcino-ma of the head and neck:current status and future direc-tions[J].Semin Oncol,2000,27(4 Suppl 8):25-33.
  • 5Soria JC,Kim ES,Fayette J,et al.Chemoprevention oflung cancer[J].Lancet Oncol,2003,4(11):659-669.
  • 6Normanno N,De Luca A,Bianco C,et al.Epidermalgrowth factor receptor(EGFR)signaling in cancer[J].Gene,2006,366(1):2-16.
  • 7Lemmon MA,Bu Z,Ladbury JE,et al.Two EGFmolecules contribute additively to stabilization of theEGFR dimer[J].EMBO J,1997,16(2):281-294.
  • 8Garrett TP,McKern NM,Lou M,et al.Crystal structure ofa truncated epidermal growth factor receptor extracellulardomain bound to transforming growth factor alpha[J].Cell,2002,110(6):763-773.
  • 9Ang KK,Berkey BA,Tu X,et al.Impact of epidermalgrowth factor receptor expression on survival and patternof relapse in patients with advanced head and neck carci-noma[J].Cancer Res,2002,62(124):7350-7356.
  • 10Grandis JR,Melhem MF,Barnes EL,et al.Quantitativeimmunohistochemical analysis of transforming growth fac-tor-αand epidermal growth factor receptor in patients withsquamous cell carcinoma of the head and neck[J].Cancer,1996,78(6):1284-1292.

共引文献13

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部